<DOC>
	<DOC>NCT02411994</DOC>
	<brief_summary>The purpose of this study is to determine the efficacy of pyronaridine-artesunate and artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Kenyan children.</brief_summary>
	<brief_title>Pyronaridine-artesunate and Artemether-lumefantrine for the Treatment of Paediatric Malaria</brief_title>
	<detailed_description />
	<mesh_term>Malaria</mesh_term>
	<mesh_term>Artemether-lumefantrine combination</mesh_term>
	<mesh_term>Artemisinins</mesh_term>
	<mesh_term>Lumefantrine</mesh_term>
	<mesh_term>Artemether</mesh_term>
	<mesh_term>Artesunate</mesh_term>
	<mesh_term>Pyronaridine</mesh_term>
	<criteria>Children between 6 months and 12 years old, with a body weight of ≥5 kg; Living in the catchment area of the study (within a radius of ~10 km from St. Jude's Clinic, Mbita, Kenya); Having microscopically confirmed P. falciparum monoinfection (asexual parasite density 1,000200,000 µL1). Signs and symptoms of severe malaria (according to WHO criteria for severe malaria, (WHO 2012)) or any other severe illness necessitating parenteral treatment; Mixed Plasmodium infection; Clinically suspected (oedema, jaundice and/or ascites) or reported hepatic and/or renal impairment (any cause, as reported by parents/guardians and/or evident from medical history); Having anaemia with an Hb &lt;6 g/dL; Evidence of severe malnutrition (severe wasting: zscore weight for age &lt;3 and severe stunting: zscore height for age &lt;3 (WHO 2009b)); Having received antimalarial therapy in the previous two weeks; Known history of hypersensitivity, allergic or adverse reactions to artesunate, artemetherlumefantrine or other artemisinins; Participating in other antimalarial drug intervention studies; Previous participation in the PAAL study, e.g. in the previous transmission season (each individual child can only take part in this study once); Not being available for followup.</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>November 2015</verification_date>
</DOC>